← Lung Cancer Targets and Therapy
Papers in Lung Cancer Targets and Therapy
Page 3 · newest first
- Detection of ROS1 rearrangement in non-small cell lung cancer: current and future perspectivesLung Cancer Targets and Therapy · 2017
- Spotlight on ramucirumab in the treatment of nonsmall cell lung cancer: design, development, and clinical activityLung Cancer Targets and Therapy · 2017
- Psychosocial challenges for patients with advanced lung cancer: interventions to improve well-beingLung Cancer Targets and Therapy · 2017
- A pilot study of zoledronic acid in the treatment of patients with advanced malignant pleural mesotheliomaLung Cancer Targets and Therapy · 2017
- Exhaled breath analysis for the early detection of lung cancer: recent developments and future prospectsLung Cancer Targets and Therapy · 2017
- Pembrolizumab in the treatment of metastatic non-small-cell lung cancer: patient selection and perspectivesLung Cancer Targets and Therapy · 2017
- Oligometastatic non-small-cell lung cancer: current treatment strategiesLung Cancer Targets and Therapy · 2016
- Radiation-induced esophagitis in lung cancerLung Cancer Targets and Therapy · 2016
- Electromagnetic navigation bronchoscopy: clinical utility in the diagnosis of lung cancerLung Cancer Targets and Therapy · 2016
- Fatigue in lung cancer patients: symptom burden and management of challengesLung Cancer Targets and Therapy · 2016
- High expression of AKR1C1 is associated with proliferation and migration of small-cell lung cancer cellsLung Cancer Targets and Therapy · 2016
- Retrospective analysis of outcomes and prognostic factors of chemotherapy for small-cell lung cancerLung Cancer Targets and Therapy · 2016
- Monitoring and management of lung cancer patients following curative-intent treatment: clinical utility of 2-deoxy-2-[fluorine-18]fluoro-d-glucose positron emission tomography/computed tomographyLung Cancer Targets and Therapy · 2016
- miRNA-21 as a novel therapeutic target in lung cancerLung Cancer Targets and Therapy · 2016
- HSP90 as a novel molecular target in non-small-cell lung cancerLung Cancer Targets and Therapy · 2016
- Nutrition support and dietary interventions for patients with lung cancer: current insightsLung Cancer Targets and Therapy · 2016
- Epiregulin as a therapeutic target in non-small-cell lung cancerLung Cancer Targets and Therapy · 2015
- First-line treatment of advanced ALK-positive non-small-cell lung cancerLung Cancer Targets and Therapy · 2015
- Targeting PD-1/PD-L1 in lung cancer: current perspectivesLung Cancer Targets and Therapy · 2015
- Non-small-cell lung carcinoma: role of the Notch signaling pathwayLung Cancer Targets and Therapy · 2015
- AXL receptor tyrosine kinase as a therapeutic target in NSCLCLung Cancer Targets and Therapy · 2015
- Hapten-enhanced therapeutic effect in advanced stages of lung cancer by ultra-minimum incision personalized intratumoral chemoimmunotherapy therapyLung Cancer Targets and Therapy · 2015
- Pemetrexed in maintenance treatment of advanced non-squamous non-small-cell lung cancerLung Cancer Targets and Therapy · 2015
- Staging lung cancer: role of endobronchial ultrasoundLung Cancer Targets and Therapy · 2014
- Targeted treatment of mutated EGFR-expressing non-small-cell lung cancer: focus on erlotinib with companion diagnosticsLung Cancer Targets and Therapy · 2014
- Clinical potential of nintedanib for the second-line treatment of advanced non-small-cell lung cancer: current evidenceLung Cancer Targets and Therapy · 2014
- Profile of bavituximab and its potential in the treatment of non-small-cell lung cancerLung Cancer Targets and Therapy · 2014
- New options in the management of intractable ALK(+) metastatic non-small-cell lung cancerLung Cancer Targets and Therapy · 2014
- Prevalence of driver mutations in non-small-cell lung cancers in the People’s Republic of ChinaLung Cancer Targets and Therapy · 2014
- Gastroesophageal junction adenocarcinoma displays abnormalities in homologous recombination and nucleotide excision repairLung Cancer Targets and Therapy · 2014
- Potential toxicity and safety evaluation of nanomaterials for the respiratory system and lung cancerLung Cancer Targets and Therapy · 2013
- Emerging treatments in lung cancer – targeting the RLIP76 molecular transporterLung Cancer Targets and Therapy · 2013
- Practical management of NSCLC patients with long-term bevacizumab treatment: a report of four casesLung Cancer Targets and Therapy · 2013
- Robotic stereotactic body radiation therapy for elderly medically inoperable early-stage non-small cell lung cancerLung Cancer Targets and Therapy · 2013
- EGFR mutations in patients with lung adenocarcinoma in southwest China: are G719S/A and L861Q more likely detected in tumors derived from smokers?Lung Cancer Targets and Therapy · 2013
- MET overexpression and gene amplification in NSCLC: a clinical perspectiveLung Cancer Targets and Therapy · 2013
- Targeted inhibition in tumors with ALK dependencyLung Cancer Targets and Therapy · 2013
- Lung cancer in womenLung Cancer Targets and Therapy · 2012
- MET targeted therapy for lung cancer: clinical development and future directionsLung Cancer Targets and Therapy · 2012
- Economic evaluation of pemetrexed versus erlotinib as second-line treatment of patients with advanced/metastatic non-small cell lung cancer in Greece: a cost minimization analysisLung Cancer Targets and Therapy · 2012
- Non-small cell lung cancer: the era of targeted therapyLung Cancer Targets and Therapy · 2012
- Update on biomarkers for the detection of lung cancerLung Cancer Targets and Therapy · 2012
- A pilot study of a metronomic chemotherapy regimen with weekly low-dose docetaxel for previously treated non-small cell lung cancerLung Cancer Targets and Therapy · 2012
- Single nucleotide polymorphisms as susceptibility, prognostic, and therapeutic markers of nonsmall cell lung cancerLung Cancer Targets and Therapy · 2011
- Nimotuzumab, a novel monoclonal antibody to the epidermal growth factor receptor, in the treatment of non-small cell lung cancerLung Cancer Targets and Therapy · 2011
- Afatinib treatment in advanced non-small cell lung cancerLung Cancer Targets and Therapy · 2011
- Effectiveness of maintenance treatments for nonsmall cell lung cancerLung Cancer Targets and Therapy · 2011
- Emerging treatment options in the management of non-small cell lung cancerLung Cancer Targets and Therapy · 2011
- Dyspnea in lung cancer patients: a systematic reviewLung Cancer Targets and Therapy · 2010
- Azacitidine and decitabine have different mechanisms of action in non-small cell lung cancer cell linesLung Cancer Targets and Therapy · 2010